Datopotamab deruxtecan la esperanza frente al cáncer de mama metastásico triple negativo
DOI:
https://doi.org/10.29059/cie.v2.dmc.75Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 https://revistacie.uat.edu.mx/index.php/cie/dautor

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


